We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

HYD Receives Approval for Phase 2 Clinical Trial

Company has received approval by the SIDC for Phase 2 clinical trial to prove the anticancer effect of deuterium-depleted water in CLL.
News

Toxic Alzheimer's protein spreads through brain via extracellular space

Neural activity accelerates its spread through the brain.
News

Optical magnetic field sensor can detect signals from the nervous system

Quantum physics: The human body is controlled by electrical impulses in, for example, the brain, the heart and nervous system. These electrical signals create tiny magnetic fields, which doctors could use to diagnose various diseases, for example diseases of the brain or heart problems in young foetuses.
News

'Poison Pill' Fed to Deadly Virus

Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
News

T2 Biosystems Ink R&D Collaboration with Bayer

T2 Biosystems and Bayer in R&D collaboration to advance drug monitoring and biomarker discovery with a blood coagulation disorder focus.
News

Improving Tumour Therapy with Nanoparticles

UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
News

'Antigen-Presenting Cell' Defends Against Cancer

Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
News

Structure of Cold Virus Solved

Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
News

ViroCyt Acquired by Sartorius

Sartorius has acquired U.S. start-up ViroCyt, expanding their bioanalytical division and reducing time of R&D and pharmaceutical production.
News

Identifying Cancer Drug Targets Using 3D-Modelling

Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Advertisement